Centessa Pharmaceuticals

Forecast & Rating12 analysts currently cover Centessa Pharmaceuticals, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $44.17, about 9.1% upside from the current price of $40.50. Price targets range from $38.00 to $62.00 — a wide spread, showing clear disagreement over just how much Centessa Pharmaceuticals can rise. Historically, about 71.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Centessa Pharmaceuticals's outlook. Data as of Jun 24, 2026; for reference only and not investment advice.